Navigation Links
Pitt receives $11 million from NIH to coordinate hepatitis B clinical research network
Date:1/29/2009

PITTSBURGH, Jan. 29 The National Institute of Diabetes and Digestive and Kidney Diseases has awarded a seven-year $11 million grant to the University of Pittsburgh Graduate School of Public Health to coordinate the Hepatitis B Clinical Research Network a consortium of 15 clinical and research centers in the U.S. and Canada that will conduct translational research on hepatitis B.

The network will include a multi-site treatment trial, create and maintain a large database of study results and store tissue and serum samples to facilitate clinical and basic research.

Hepatitis B is an infection that affects the liver. About 1.5 million Americans and 350 million people worldwide have chronic hepatitis B infection, which can lead to more serious diseases such as cirrhosis, liver failure and liver cancer.

"Medical advances have led to many treatments for chronic hepatitis B infection and most patients respond to them," said Steven Belle, Ph.D., principal investigator of the data coordinating center and professor of epidemiology, University of Pittsburgh Graduate School of Public Health. "However, these treatments do not cure the infection, but contain it by making it more difficult for the virus to reproduce."

Many patients need to stay on therapy for a long time, he added. And when treatment is prolonged, the virus can become resistant, making further treatment ineffective.

"We don't know why treatment works better for some patients than others, and we cannot accurately predict who may go on to develop liver abnormalities," said Dr. Belle. "But with the interdisciplinary expertise within the network, we hope to learn more about the immune changes that occur with hepatitis B infection and make inroads to finding a lasting cure."


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1

Related medicine news :

1. ProAssurance Receives Regulatory Approvals for Transactions with the PICA Group and Georgia Lawyers Insurance Company
2. PEAK Surgical Receives European CE Mark for PEAK(R) Surgery System for Use in General Surgery
3. Mylan Receives Final FDA Approvals for Generic Versions of Lamictal(R) Tablets and Lamictal(R) CD
4. UTSA receives federal funding for fossil fuel research
5. ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica
6. UTSA receives $1.2 million gift from Kleberg Foundation
7. IPC The Hospitalist Company Receives Best IPO Award from Los Angeles Venture Association
8. Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
9. YMCA of Greater Pittsburgh Receives $500,000 from McAuley Ministries for New Hill YMCA Roof
10. CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
11. MSU researcher receives $1.5 million grant for childhood obesity intervention study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... IL (PRWEB) , ... December 07, 2016 , ... AlignLife ... season. Many children are not fortunate enough to receive bountiful gifts wrapped tightly ... unwrapping presents can bring to the children of the world. , In exchange for ...
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 ... ... A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... dogs. The study was published in the prestigious Journal of Veterinary Science & ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and Laser ... Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now Through ... Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in time ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s ... in the Folio: Marketing Awards competition. Live From won in the Use of ... inventive, and ultimately successful projects undertaken by the media industry’s most innovative marketing ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... -- According to responses from U.S. oncologists that participated in ... with non-small cell lung cancer (NSCLC), treatment decisions are made ... status. The findings of the survey were presented today as ... ) at the 2016 World Conference on Lung Cancer (WCLC) ... survey results revealed an overall high rate of EGFR mutation ...
(Date:12/7/2016)... Conn. , Dec. 7, 2016 ... II trial in patients with unresectable malignant pleural ... survival (PFS). The data, presented at the 17 ... in Vienna , showed nintedanib ... to placebo plus pemetrexed/cisplatin, with a significantly improved ...
(Date:12/7/2016)... YORK , December 7, 2016 ... Pharmaceuticals PLC (NASDAQ: JAZZ ), Anthera Pharmaceuticals Inc. ... DNAI ), and AveXis Inc. (NASDAQ: AVXS ... Sector Index fell roughly 37% to reach a level equal ... it is down by approximately 14% for the year, it ...
Breaking Medicine Technology: